Diagnosis and Management of Heavy Menstrual Bleeding in Adolescents

Initial Evaluation and Diagnosis

Menarche at age 9 is early but within the range of normal, and heavy bleeding in early adolescence often reflects anovulatory cycles due to immature hypothalamic-pituitary-ovarian axis, but pathology must be excluded, according to the American Academy of Pediatrics 1
This age group requires particularly careful evaluation for bleeding disorders, as inherited coagulopathies often present with menorrhagia at menarche, as noted by the American Society of Hematology 2
Laboratory evaluation should include complete blood count to assess for anemia and thrombocytopenia, coagulation studies to screen for bleeding disorders, and consideration of von Willebrand disease testing and platelet function studies if family history or other bleeding symptoms present, as recommended by the American Society of Hematology 2
Clinical assessment should document Pictorial Bleeding Assessment Chart (PBAC) score to objectively quantify blood loss, and associated symptoms such as dysmenorrhea, easy bruising, epistaxis, and gingival bleeding, according to the International Society on Thrombosis and Haemostasis 3, 4, 2

The American College of Obstetricians and Gynecologists recommends NSAIDs, such as mefenamic acid or naproxen, as first-line medical management for heavy menstrual bleeding in adolescents, with dosing during menstruation only (5-7 days of treatment) 5
Tranexamic acid is a highly effective non-hormonal option that reduces menstrual blood loss by up to 50%, and is particularly useful if NSAIDs are contraindicated or ineffective, as noted by the American College of Radiology 6
Hormonal therapies, such as combined oral contraceptive pills, should be reserved for cases where first-line medical management fails or is contraindicated, and can provide excellent cycle control and reduce menstrual blood loss, according to the American Academy of Pediatrics 1

Up to 20% of adolescents with heavy menstrual bleeding have an underlying bleeding disorder, and von Willebrand disease is the most common inherited bleeding disorder in this population, as noted by the American Society of Hematology 2
Immune thrombocytopenia (ITP) can present with menorrhagia, and hematology consultation is recommended if bleeding disorder is suspected, according to the American Society of Hematology 2
High-dose estrogen therapy and transfusion may be necessary for acute control of severe bleeding, and antifibrinolytic agents such as tranexamic acid can be added, as recommended by the American Society of Hematology 2, 3, 4